secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001493152-25-011867
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health Q2 revenue stable at $2.4M; H1 gross margin improves to 66.1%
--------------------------------------------------------------------------------

- Q2 product revenue $2.404M vs $2.423M YoY; commercial portfolio AUP up 12%.
- H1 2025 revenue $4.683M (+2.3% YoY); gross margin 66.1% (vs 57.6% in H1 2024).
- Operating expenses down 31% to $8.1M; cash burn reduced 41% to $4.8M in H1.
- Sales force cut from 19 to 7 FTEs; sales per FTE up 156% in Q2.
- CEO Mike Buhle reaffirms ENDOInform milestone completion by end of 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000149315225011867/0001493152-25-011867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000149315225011867/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer